Press Release
Ondas Holdings Reports Third Quarter 2024 Financial Results: Secures $14.4 Million in Drone Platform Purchase Orders in Q3
Q3 marks the largest bookings in Ondas' history $14.4 million in purchase orders were from a major military customer for the Iron Drone Raider and Optimus System autonomous drone platforms Iron Drone Raider is emerging as a best-in-class 'hard kill' counter drone solution addressing the urgent need for protection from hostile drones Order from Metra, Chicago's primary commuter rail system, for system-wide 900 MHz upgrade secured by partner Siemens Railroads communicate plans for general purpose 900 MHz network architecture to be deployed to support resilient rail operations Conference Call Scheduled for Today at 8:30 a.m. ET Read More
Press Release
Resident and Nonresident Life Insurance and Annuity Agents in California Can Stay Compliant and Obtain New Training Requirements With Approved Coursework From A.D. Banker
With changes impacting every licensed agent selling non-term life insurance policies, variable life insurance policies, and/or annuities in the state of California, agents can get the guidance they need from a seasoned educator Read More
Press Release
GHGSat Announces Rapid Expansion, Near-Doubling Its Fleet of Methane Emissions-Monitoring Satellites by 2026
This sharp growth will allow GHGSat's pioneering constellation—already the world's largest collection of satellites dedicated to monitoring greenhouse gases—to revisit industrial sites to detect methane emissions on a daily cadence around the world. Read More
Press Release
Jaguar Health to Hold Investor Webcast Wednesday, November 13th at 8:30 AM Eastern Regarding Q3 2024 Financials & Corporate Updates
Click here to register for investor webcast Company plans to file its Earnings Report on November 13, 2024 on Form 10-Q for the quarter ended September 30, 2024 Read More
Press Release
First-in-Class Bispecific Antibody, ALG.APV-527, Meets Important Trial Endpoints in Phase 1 Solid Tumor Trial
Aptevo Therapeutics and Alligator Bioscience report favorable safety, tolerability and evidence of biological activity of ALG.APV-527, more than half of evaluable patients achieved stable disease Colon cancer patient achieved stable disease and remained on study for more than six months, breast cancer patient remained on study for more than 11 months Biomarker analysis confirms immune activation in the tumor microenvironment Data Presented at Society for Immunotherapy of Cancer on November 8, 2024 Read More
Press Release
Discovery Senior Living's SHINE® Memory Care Program Earns Third Recognition From the Alzheimer’s Association® Curriculum Review
Training for the proprietary program is aimed at implementing the latest evidenced-based approaches to dementia care amid the growing numbers of Americans affected. Read More
Press Release
